Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Managed care in the genomics era: assessing the cost effectiveness of genetic tests.

The American journal of managed care - 1 Jul 2003

Higashi Mitchell K, Veenstra David L

Abstract excerpt

BACKGROUND: Despite the fact that the Human Genome Project was completed only recently, genetic tests already have entered the marketplace, some with few or no long-term data to support their use. Managed care organizations will face reimbursement decisions for genetic tests on a growing scale, a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Decision Making
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Human Genome Project

Share to United States

Source

Identifiers

PMID: 12866628

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-12866628-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Managed care in the genomics era: assessing the cost effectiveness of genetic tests.PMID 12866628Read ↗

Assessing the cost-effectiveness of pharmacogenomics.Semantic proximity Read ↗

The Economics of Pharmacogenomics.Semantic proximity Read ↗

msJAMA. Genomics in medicine and public health: role of cost-effectiveness analysis.Semantic proximity Read ↗

Pharmacogenetics and cost-effectiveness analysis: a two-way street.Semantic proximity Read ↗

Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?Semantic proximity Read ↗

Economic evaluations of pharmacogenetic and genomic screening programs: update of the literature.Semantic proximity Read ↗

Genomic testing in oncology to improve clinical outcomes while optimizing utilization: the evolution of diagnostic testing.Semantic proximity Read ↗

Clinical Validity and Clinical Utility of Genetic TestsSemantic proximity Read ↗

Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review.Semantic proximity Read ↗

Economic evaluation of pharmacogenetic tests.Semantic proximity Read ↗

Value-based genomic screening: exploring genomic screening for chronic diseases using triple value principles.Semantic proximity Read ↗

Evaluating the value of genomic diagnostics: implications for clinical practice and public policy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.